GBT
DGX icon

Grove Bank & Trust’s Quest Diagnostics DGX Stock Holding History

Grove Bank & Trust’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$89.4K Buy
422
+300
+246% +$58.9K 0.01% 360
2026
Q1 		$23.9K Hold
122
– – ﹤0.01% 517
2025
Q4 		$21.2K Hold
122
– – ﹤0.01% 538
2025
Q3 		$23.3K Hold
122
– – ﹤0.01% 519
2025
Q2 		$21.9K Buy
122
+14
+13% +$2.43K ﹤0.01% 522
2025
Q1 		$18.3K Buy
108
+93
+620% +$15.3K ﹤0.01% 532
2024
Q4 		$2.26K Buy
+15
New +$2.33K ﹤0.01% 676
2017
Q4 		– Sell
-60
Closed -$6K – 531
2017
Q3 		$6K Hold
60
– – ﹤0.01% 506
2017
Q2 		$7K Buy
+60
New +$6.34K ﹤0.01% 515

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Grove Bank & Trust's DGX Position: Q2 2026 in Review

Grove Bank & Trust increased its Quest Diagnostics (DGX) stake by 246% in Q2 2026, buying an estimated $58.9K and bringing the position to 422 shares worth $89.4K. The position accounts for 0.01% of the portfolio, ranked #360.

Grove Bank & Trust first reported a position in DGX in Q2 2017 and has held it in 9 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Grove Bank & Trust held 422 shares of Quest Diagnostics worth $89.4K as of Q2 2026.
  • Grove Bank & Trust bought 300 Quest Diagnostics shares in Q2 2026, an estimated $58.9K.
  • Quest Diagnostics made up 0.01% of Grove Bank & Trust's portfolio in Q2 2026, its #360 holding.
  • Grove Bank & Trust first reported a position in Quest Diagnostics in Q2 2017 and has held it in 9 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.